Benzinga | Aug 12, 2021 08:29AM EDT

Aptevo Therapeutics Q2 EPS $(1.75) Up From $(2.10) YoY

Aptevo Therapeutics (NASDAQ:APVO) reported quarterly losses of $(1.75) per share. This is a 16.67 percent increase over losses of $(2.10) per share from the same period last year.